PD-L1 nano Antibody

Sizes: 50μL, 100μL

Catalogue Numbers: RA20449-50, RA20449-100

Citations, Manuals and MSDS Available upon request.

Background: CD274 molecule (CD274) Homo sapiens This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015],

Condition: Liquid in PBS

Storage Instructions: -20°C/1 year

Recommended dilutions: ELISA 1:10000-20000

Alternative Names: Programmed cell death 1 ligand 1 (PD-L1) (PDCD1 ligand 1) (Programmed death ligand 1) (B7 homolog 1) (B7-H1) (CD antigen CD274)

Applications: FCM; ELISA

Species Cross-Reactivity: Human; Mouse

GeneID (Human): 29126

SWISS: Q9NZQ7

Source: Camel

Research Use Only